Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Oman
Summary - Phy-Nfm-0266 Rufinamide Tablet 400 Mg 720, Phy-Nfm-1180 Rimegepant Tablet 75 Mg 120, Phy-Nfm-0834 Benralizumab 30Mg Sc 21, Phy-Nfm-0830 Dupilumab Inj 200Mg/1.14Ml For S.C 27
Deadline - Jan 20, 2025
GT reference number - 99619742
Product classification - Medical equipments, pharmaceuticals and personal care products
Address - Oman
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 99619742
Document Type - Tender Notices
Description - notice_title: Phy-Nfm-0266 Rufinamide Tablet 400 Mg 720, Phy-Nfm-1180 Rimegepant Tablet 75 Mg 120, Phy-Nfm-0834 Benralizumab 30Mg Sc 21, Phy-Nfm-0830 Dupilumab Inj 200Mg/1.14Ml For S.C 27local title:: PHY-NFM-0266 RUFINAMIDE TABLET 400 MG 720, PHY-NF M-1180 RIMEGEPANT TABLET 75 MG 120, PHY-NFM-0834 BENRALIZUMAB 30MG SC 21, PHY-NFM-0830 DUPILUMAB INJ 200MG/1.14ML FOR S.C 27 tender_quantity: 720, 120, 21, 27Document Fee: : 25
Gt Ref Id - 99619742
Deadline - Jan 20, 2025
Similar Tenders :
Join to access thousands of business opportunities
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database
